ã¡ãã£ã¢èšäº
ãã³ããã«ã¯ã³ãããã¶ã€ãããã®çºæ³ã§æ°åã³ãããŠã€ã«ã¹ãæéã§ããå¯èœæ§
ããºãææ°ããŒã¯ 484
twitterã³ã¡ã³ã 183ä»¶äž 1ïœ100件
ïŒã¯ã¯ãã³ã§æªåãããªããã°ã錻氎ãåºãããã«ã¿æ ªããšãããã®ãããã ã£ãã®ã§ã¯ïŒãã®ãåææ¬ é¥ãŠã€ã«ã¹ãã¯ãSARS-CoV-2ã®3åã®éãã§èªå·±è€è£œããŠSARS-CoV-2ã®å¢æ®ãé»æ¢ãããã...
ãã®æãã®æã®æ°åã³ããæéæ³ããã®çºæ³ã¯é¢çœããªãç 究é²ã¿ãŸãããã«â
æ¬ æéºäŒåãæ£èŠçãé§éããçç±ãšããŠã¯å€æ§æ§ã®æ
ä¿ãæšçã§ããã䌞ã³ããã倱ã£ãçš®ã¯ã¢ãããŒã·ã¹ãèµ·ãããŠç«¶äºã®ãã£ã³ã»ã«åŸ
ã¡ã«åžãè²ã
çºæ³ããããæããµããâŠã
ããã ãããã£ã€ã«ã§ããŠç±³ã«åºæ¥ã¬èš³ããªããæãããŠã¯ã¯ãã³ã¡ãŒã«ãŒæ²¢å±±ããããããã®ããåé¡ã
ä»ã®æ¥æ¬ã«ã¯ãã§ãã¬ð
ä»ã®æ¥æ¬ã«ã¯ãã§ãã¬ð
ãããã®èšäºã®èµ€ãçãã€ãããŠã€ã«ã¹ã®åçãäžå¹ŽåããªãŸããŸèŠãããããã®ã ãåŸãèµ€ãç²ã
ã®éšåãäžåã«ãªã£ããã®ã匷調ããŠããããããŸã èŠã€ãã£ãŠãªãã
åºããããã±ã¢ã³ã«ã¯ãã±ã¢ã³ãã¶ã€ããã ããçè«ããè²åvs䌜怰åããã
å
æ¥ã®ãã€ãŒããçŸå®ã«ïŒïŒ
ð®ð¥©ããŒã»ããšã«å¹ããªããšã£ãšãšéçºãã¡ãã£ãŠã¿ãŠãã ããããšèããæŽãå¢ãã§åæããŸãã
ã³ããVSã·ã³ã»ã³ãã
æ»æçšã³ããã®å€ç°ã¯ãªãã®ã ãããïŒã
ããã倱æãããã倧æšäºã«ãªãããããããŠã»ããðŠ
å®éã«äœ¿ãããã©ããã¯å¥ãšããŠãããããå¿çšç 究ã«è³ããçºã®åºç€ç¥èãç 究ã£ãŠæ¬åœã«å€§åããæ¥æ¬ã«äžçªè¶³ããªããã€ã
ãã±ã¢ã³ã«ã¯ãã±ã¢ã³ãã¶ã€ããã ãïŒãšããè³èšã
ãªãâŠ
ãªãâŠ
ãã®çºæ³ãã§ãã人é¡ãæããâŠ
ãããè€ãèšèã ãã©
ãããè€ãèšèã ãã©
ãã®å€ç°ããå€ã®ææã®5åãšãªã£ãæšå¹Žåæ§ã«ãã®å¬ã«æ¥ãã°ãå©æš©ã§èº«åãã®åããªãèªæ°å
æ¿æš©ã®ãŸãŸã§ã¯æ¥æ¬ã¯ç Žæ»
çå±æ©ãè¿ããâŠ
ïŒ
ïŒ
æåŸ
ããããª
ã§ãããããã
ïŒã²ãã ã«æ¬ æã®ãããŠã€ã«ã¹ããæ£åžžãªãŠã€ã«ã¹ã®å¢æ®ã劚ãããå¹²æžãã®åããå©çšãã¹ãããæ¬ é¥å¹²æž(DI)ç²åãã«ããã³ããæ²»çæ³ã
人éã¯ã³ããã«åã€ãããªâŠ
人éã¯ã³ããã«åã€ãããªâŠ
ããã¯ã€ãããã¹ãã€ã¯èçœã®éºäŒæ
å ±ã ãã®mRNAã¯ã¯ãã³ãšéã£ãŠãŠã£ã«ã¹ãã®ãã®ãçç©å
µåšãšåãããã
èªåã§ææåºããããããäžäººäžäººæ¥çš®ããå¿ èŠã¯ãªããªã©ã¡ãªããã倧ãããã©ã
ãã£ãšã€ããå€ç°æ ªãåºãŠããŠã©ããããããªããªã£ãæã®æçµæ段ãããã
èªåã§ææåºããããããäžäººäžäººæ¥çš®ããå¿ èŠã¯ãªããªã©ã¡ãªããã倧ãããã©ã
ãã£ãšã€ããå€ç°æ ªãåºãŠããŠã©ããããããªããªã£ãæã®æçµæ段ãããã
ãã®ãã€ãŒãã¯åè«ã®ã€ããã ã£ãã®ã ããã©ããã¡ãã¯æ¬æ°ã®åãçµã¿ã
ããã¯ãšãããåç©å®éšã®çœªãæ·±ãèžã«å»ãã§ãã
ããã¯ãšãããåç©å®éšã®çœªãæ·±ãèžã«å»ãã§ãã
ããããã¯å¯èœæ§ã®äžã€ã ãšæãããã«ã¿æ ªããæææ§ã匷ãã£ãŠãã§ãç
åæ§ã®ãªã人工ãŠã£ã«ã¹ãäœãããšãã§ããã°åé¡ã¯è§£æ±ºãããã§ãä»ã®æè¡ãªããã§ããªããããããªãã
ã©ããŸã§æåŸ
ã§ããã®ãïŒããããå¯èœãªã®ãïŒäžæãªç¹ãå€ãããå¯èœæ§ãããã®ã§ããã°æåŸ
ããåŸ
ã£ãŠã¿ããã
çŽ äººèãã ãã©ããããããŸãæ°ããªå€ç°æ ªèªçãã¡ããå¯èœæ§ãªãã®ãïŒ
ãã¶ãããå±ãªãã
SARS-CoV-2ã现èå ã«å ¥ãã«ã¯ã¹ãã€ã¯(S)ã¿ã³ãã¯è³ªãå¿ èŠãªã®ã§ãããã¯æ¬ æããŠãªãã¯ãã
ã§ãSã¿ã³ãã¯è³ªã¯ããèªäœã«ç åæ§ãããã®ã«ãããã3åã®ã¹ããŒãã§å¢ãããâŠãšãã話
SARS-CoV-2ã现èå ã«å ¥ãã«ã¯ã¹ãã€ã¯(S)ã¿ã³ãã¯è³ªãå¿ èŠãªã®ã§ãããã¯æ¬ æããŠãªãã¯ãã
ã§ãSã¿ã³ãã¯è³ªã¯ããèªäœã«ç åæ§ãããã®ã«ãããã3åã®ã¹ããŒãã§å¢ãããâŠãšãã話
ã³ããããã£ãŠã³ãããå¶ãïŒïŒ
æ²»çïŒã®æ±ºå®æã«ãªãã®ããªïŒ
ãªã«ã«ããŠããã³ããã®å ±å°ããäœå ã§å±éãããšæããšãŸããšããã
æ²»çïŒã®æ±ºå®æã«ãªãã®ããªïŒ
ãªã«ã«ããŠããã³ããã®å ±å°ããäœå ã§å±éãããšæããšãŸããšããã
ææåã匷ã匱æ¯åããã³ãããŠã£ã«ã¹ã匷æ¯åããŠãããã«ãã¹ããã¢ã«ãªãæªæ¥ããèŠããªã
çºæ³çã«ã¯åé¡ç¡ãã®ã§ãããã...ãã®ç 究ãåæçãªãã®ã§ããã°ð§
ã²ãã ã«æ¬ æã®ãããŠäº»ïŸïŸã¹ããæ£åžžãªãŠäº»ïŸïŸã¹ã®å¢æ®ã劚ããã
ã²ãã ã«æ¬ æã®ãããŠäº»ïŸïŸã¹ããæ£åžžãªãŠäº»ïŸïŸã¹ã®å¢æ®ã劚ããã
ãªãããããããšã«ãªã£ãŠãã
çç©åŠã®éå€æŒ¢ã«ã¯ãããæãããªãïœã
åºå žå â
åºå žå â
åææ¬ é¥ãŠã€ã«ã¹(ç¡å®³)ã人工çã«äœã£ãŠæ¬ç©ã®ã³ãããŠã€ã«ã¹ã«ã¶ã€ããâŠ
çŽ äººã«ã¯äœã ã話ãã®äžçã«ãªã£ãŠãã¿ããã§ããå¯èœã§æå¹ã§å®å šãªãã§ãããïŒ
äžæŽ»åã¯ã¯ãã³ã¿ãããªãã®ïŒ
çŽ äººã«ã¯äœã ã話ãã®äžçã«ãªã£ãŠãã¿ããã§ããå¯èœã§æå¹ã§å®å šãªãã§ãããïŒ
äžæŽ»åã¯ã¯ãã³ã¿ãããªãã®ïŒ
ãç 究ãé²ããŠåŸ®èª¿æŽãå ããã°ãåæDIç²åãCOVID-19ã®æ²»çè¬ãšããŠäœ¿ããããã«ãªãå¯èœæ§ããããŸãã
人é¡ã®åœéãè³ãããåæãã§ããª
ã€ãããããã¯ã
人é¡ã®åœéãè³ãããåæãã§ããª
ã€ãããããã¯ã
ã»ã»ã
ïŒïŒ
匱æ¯æ ªãã
ãããã³ããã«æäœã®ã¢ã¿ãã€ããããŠåŒ·æ¯æ ªæœ°ããšãããããããã
ãããã³ããã«æäœã®ã¢ã¿ãã€ããããŠåŒ·æ¯æ ªæœ°ããšãããããããã
ä»äœ¿ã£ãŠãããããªã¯ã¯ãã³ã«äŒŒãçºæ³ããªãšæããŸãããæ²»çè¬ã«äœ¿ããããã§ãã
èŠã¯ãçã¯ã¯ãã³ãã§ãããããŸãããªãªãªãããšåãRNAãŠã€ã«ã¹ã¯å€ç°æ©ãããçå±çã«ã¯ãã£ã¡ã®ãåããŠããã©ãç¡å®³åãšãªããšè²ã
ãªã¹ã¯ãâŠ
è²å vs 䌜怰å ã¿ãããªãããããŠã€ã«ã¹ã ãã«ã
ã㌠ãã£ã±ãåºããïŒ
匷æ¯æ§ã§ææåã®åŒ·ãæ ªãçªç¶åºçŸããŠéåžžã®ã¯ã¯ãã³æ¥çš®ã§ã¯å¯Ÿå¿ã§ããªãå Žåã«ã¯ãããæçµå µåšã«ãªãããïŒ
匷æ¯æ§ã§ææåã®åŒ·ãæ ªãçªç¶åºçŸããŠéåžžã®ã¯ã¯ãã³æ¥çš®ã§ã¯å¯Ÿå¿ã§ããªãå Žåã«ã¯ãããæçµå µåšã«ãªãããïŒ
æå¹ãªæ段ãªã®ãã¯åãããªãããããã俺ãã«ã ãã詳ããããšã¯åãããããã©ãæ§ã
ãªç 究ãè¡ãããŠããã®ã¯ãšãŠãå¿åŒ·ãã
äžåŠè«æŸé£Œæ³ã¿ãããª
é£ããããšã¯ããããªããã©ããããäºå®ãªãéã®ç©Žãããã®åžæã¯èŠããŠããã®ããïŒ
å»åŠã®ããšã¯ãã解ããã
ãçã¯ã¯ãã³ãã®ãããªãã®?
ãçã¯ã¯ãã³ãã®ãããªãã®?
--
ããã
ããã
çŽ äººèãã§ãã
ã³ã¬ã¯ã€ããç¡ãã§ããïŒ
人工ãŠã£ã«ã¹ãå€ç°ããŠæ匷ãŠã£ã«ã¹ã«ãªã£ããããªãã®ïŒð¥º
ã³ã¬ã¯ã€ããç¡ãã§ããïŒ
人工ãŠã£ã«ã¹ãå€ç°ããŠæ匷ãŠã£ã«ã¹ã«ãªã£ããããªãã®ïŒð¥º
ãã·ã¥ïŒãã·ã¥ïŒ(é¡åŸ®é¡åçãæ¡å€§ãããã³è¬ã®å¹æé³)
ãã¬ãŒã·ã§ã³ã人é¡ãæãããã«äœããããã®äººå·¥ãŠã€ã«ã¹ã¯ãç¡å®³ãªæ¬ é¥åã®ã¯ãã ã£ãâŠã
ãŠäºåç·šã§çµ¶å¯Ÿãããã
ãã¬ãŒã·ã§ã³ã人é¡ãæãããã«äœããããã®äººå·¥ãŠã€ã«ã¹ã¯ãç¡å®³ãªæ¬ é¥åã®ã¯ãã ã£ãâŠã
ãŠäºåç·šã§çµ¶å¯Ÿãããã
ãã®ååããããŠãããã¢ã³ãã³ãããŠã€ã«ã¹ã¯å®éã«ç 究ãããŠããã®ã
倩ç¶çã«å¯ŸããŠã®ççã¯ã¯ãã³æãåºããªã
ãã³ããã«ã¯ã³ãããã¶ã€ãã :
- - -
ã²ãã ã«æ¬ æã®ãããŠã€ã«ã¹ãæ£åžžãªãŠã€ã«ã¹ã®å¢æ®ã劚ããåãããå¹²æžããæ¬ é¥ãŠã€ã«ã¹ç²åããDIç²åããšåŒã¶ãç 究ããŒã ã¯ãSARS-CoV-2ã®ã²ãã ã90ïŒ ã«ããããŠãSARS-CoV-2ã®DIç²åããéçºã
- - -
ã²ãã ã«æ¬ æã®ãããŠã€ã«ã¹ãæ£åžžãªãŠã€ã«ã¹ã®å¢æ®ã劚ããåãããå¹²æžããæ¬ é¥ãŠã€ã«ã¹ç²åããDIç²åããšåŒã¶ãç 究ããŒã ã¯ãSARS-CoV-2ã®ã²ãã ã90ïŒ ã«ããããŠãSARS-CoV-2ã®DIç²åããéçºã
è²åVS䌜怰åçè«ã§ãšãã§ãããŒãã±ã¢ããŠã£ã«ã¹ãã§ããå¯èœæ§ã¯ãªãã®ããã
"ç 究ãé²ããŠåŸ®èª¿æŽãå ããã°ãåæDIç²åãCOVID-19ã®æ²»çè¬ãšããŠäœ¿ããããã«ãªãå¯èœæ§ããããŸã"
â» æ¬ é¥å¹²æž(DI)ç²å:å¹²æžãåŒãèµ·ãããããªæ¬ é¥ãæã£ããŠã€ã«ã¹ç²å
â» æ¬ é¥å¹²æž(DI)ç²å:å¹²æžãåŒãèµ·ãããããªæ¬ é¥ãæã£ããŠã€ã«ã¹ç²å
åœç©ãæ¯æã€ããšã¯ãªãã®ããªã
æ¯éãšãè¬ã«ããŠããã
ãããªããšãåºæ¥ããšã¯ããã¯ãæ°åã³ããã¯äººå·¥ãŠã€ã«ã¹ãªãã ããã
ãããªéŠç»ãã£ããªãïŒè²kâŠããµãããµã
ç£ç£ã® ã«ã¯è²ã
ãšè¿æªæ¥ã®äºèšã«ã䌌ãèšå®ãè²ã
ãããã©ããŸããã® ã®å
·çŸåãšã¯âŠ
Portal2ã§æ¬ æã¿ã¬ããäœã£ãŠãã®ãæãåºãèšäºå
容ã ã£ã
âŠâŠæ°åã®FOXDIEã§åæåã®FOXDIEãé§éããã¿ãããªâŠâŠïŒïŒïŒïŒïŒïŒïŒ
åãç©ã«ã¯åãç©ãã¶ã€ãããã ãïŒïŒ
ã®åçã§ããã
ã®åçã§ããã
ããã¯èå³æ·±ãïŒçäœã§ã®å®éšãŸã§é²ãã§ããïŒ
ããã±ã¢ã³ã«ã¯ãã±ã¢ã³ãã¶ã€ããã ãããé ãããã£ãïŒãªãæåŸïŒ
確ããå£è¹ç«ã ã£ããäœããåæ§ã®ã¯ã¯ãã³ã§æ ¹çµ¶ããããããªãã£ãããªïŒ
ä»ã¯æŠæŒ¢ç±ã§ã€ã³ãã«ãšã³ã¶ããã£ã€ããŠããç¶æ ã ããã©âŠã
ä»ã¯æŠæŒ¢ç±ã§ã€ã³ãã«ãšã³ã¶ããã£ã€ããŠããç¶æ ã ããã©âŠã
ãã ã®ã¯ã¯ãã³ããªãšæã£ãããããããïŒMGS4ã®æ°åFOXDIEã§å€ç°FOXDIEãè¿œãåºãããã€ãããïŒ
äžã€ã®å¯èœæ§ã§ã¯ãããšæããŸããããããæ°åã³ãã詳现ãªçŽ æ§ãéçåã¡ã«ããºã ãã解æã§ããŠããªãç¶æ³ã§æãä»ããããšã¯å±éºã§ããäžçã¯æŠæŒ¢ãæ¹å€ããŸããããããããšã¯åãã§ãã
èãããäºãå±±ã»ã©ããã
ïŸïŸ
ã«ã¯ïœºïŸïŸ
ãã¶ã€ãããã®çºæ³ã§æ°åïŸïŸ
ïŸïœœãæéã§ããå¯èœæ§
ãã£ïœ€ æ¢ã«ïŸïœžïŸïŸæ¥çš®ã§ãã£ãŠãã®ã§ã¯ïŒ(?_ïŒ)
ãã£ïœ€ æ¢ã«ïŸïœžïŸïŸæ¥çš®ã§ãã£ãŠãã®ã§ã¯ïŒ(?_ïŒ)
é¢çœããªãããããã§æ²»çè¬ãåºæ¥ãã°ããã®ã«ãªãŒ
ããã©ãŒã§ãããïŒ
ãã±ã¢ã³ã«ã¯ãã±ã¢ã³ãã¶ã€ããã ãïŒ
ããããããããŠãåŠæ³ãçŸå®ã«ãªããïŒ
ãªããŠæ·±ããã
ãã€ãžã§ããªãããããïŒ
åãç©ã«ã¯åãç©ãã¶ã€ããçµæã
æå¶ææªã®åãç©ãç£ãŸããæ ç»ããã£ãŠã ãªâŠ
æå¶ææªã®åãç©ãç£ãŸããæ ç»ããã£ãŠã ãªâŠ
京倧 ãŠã€ã«ã¹ã»åçå»ç§åŠç 究æ åææ 宮沢å幞ã¯ã³ãããŠã€ã«ã¹ã®åææè¡ã®ãããžã®è»¢çšãèãã
èšäºäžã®ç 究è ãã¡ã¯ååææè¡ã§ã³ããå æã暡玢ããŠãã
ãã®éãã¯æãŠããªã倧ãã
èšäºäžã®ç 究è ãã¡ã¯ååææè¡ã§ã³ããå æã暡玢ããŠãã
ãã®éãã¯æãŠããªã倧ãã
è²åvs䌜怰åããã
ã ãæéã§ããå¯èœæ§ ãŸãã«
ããŒããããã
å®çŸå¯èœãªãåãâŠæéãããããïŒ
æ©ãããŠããã
çŽ äººãªããç 究è ä»»ãã§ãã¿ãŸããïŒÏïŒ
ããŒããããã
å®çŸå¯èœãªãåãâŠæéãããããïŒ
æ©ãããŠããã
çŽ äººãªããç 究è ä»»ãã§ãã¿ãŸããïŒÏïŒ
é¢çœãåãçµã¿ã
ã³ããæ²»çã«ç¡å®³åããã³ããã䜿ãã¢ã€ãã£ã¢ã
é£ããã®ã¯ã³ã¬ãå€ç°ãåŸãããšãåç¬ã§ã®è€è£œèœåãæã£ãæã«ééãªãææããŠããŸããªããã
(æµæ§ã³ãããŠã€ã«ã¹ãšäžç·ã«æ»æ» ãããã©ãã)
ã³ããæ²»çã«ç¡å®³åããã³ããã䜿ãã¢ã€ãã£ã¢ã
é£ããã®ã¯ã³ã¬ãå€ç°ãåŸãããšãåç¬ã§ã®è€è£œèœåãæã£ãæã«ééãªãææããŠããŸããªããã
(æµæ§ã³ãããŠã€ã«ã¹ãšäžç·ã«æ»æ» ãããã©ãã)
ééããããã ãšã«ãã·ãã ãã®ãšã³ãããŒãç¡ãã®äžå®å
šãŠã€ã«ã¹ãªã®ã§åææããªãããšã«ã - ãæåŸã«ã¯åŽ©å£ãã现èããç¡æ°ã®ãŠã€ã«ã¹ç²åãæŸåºãããããšã§ã
ïŒæ£åžžãªãŠã€ã«ã¹ã®å¢æ®ã劚ããåãã¯åŠè¡çã«ã¯ãå¹²æžããšããããã®å¹²æžãåŒãèµ·ãããããªæ¬ é¥ãæã£ããŠã€ã«ã¹ç²åã¯ãæ¬ é¥å¹²æž(DI)ç²åããšåŒã°ããŠããŸãã
人ã®æå¿ã¯æãŠããªãð
人ã®æå¿ã¯æãŠããªãð
ããã¯èå³æ·±ãæ¹åæ§âŠç 究ãé²ãã§æ¬²ããã
>
>
é£ããããšã¯ããããããªãããæ¯ã以ãŠæ¯ãå¶ããã
: ããç¥ã£ãŠããæåŸã«ã¯åã蟌ãŸããŠå®å
šäœãäœãåºãããŠäººé¡æ»
亡ãããã€ã
ææ¬ãã£ã³ãã«çæŸéè¯ãã£ãã§ããã³ããæ²»çã«é¢ããæ°ããèšäºãåºãŠããŸããã®ã§æ·»ä»ãããŠé ããŸãã
ãžããããããã
å¹æãããªããšãé¢ä¿ãªããè
åšãæã£ãŠè
åšãå¶ããšããã¯ãŒãã ãã§ãªããåšäºç
å¿ãããããã
ãã±ã¢ã³ã«ã¯ãã±ã¢ã³ãâŠïŒ
ããããããæ¹åã®æ€èšãå¿
èŠã ããã
ã¯ã¯ãã³ãããã¡ããã
ã¯ã¯ãã³ãããã¡ããã
ä»æ¥ã®ã¡ã¢2021/8/25ãã
ãžãäœããã®ãããã?ð·
ããããçºæ³å¥œã
ãã±ã¢ã³ã«ã¯ãã±ã¢ã³ã¶ã€ããã ãã®çºæ³ãããª
å®éšããŠæå¹æ§ã確ãããŠã»ãããä»ã¯ã©ããªæ段ã§ãæ€èšããããã
ãã³ãããé²åãç¶ããã®ãªããåç®ã¯ãããŸãããé²åã®ä¿é²ããïŒé²åã®çµçå°ç¹ã¯èªæ»
ãæ»ãã®ãã®ã ãããªãã°ãé²åããã¡ãã§ä¿é²ãããŠããã°ããèš³ããèªæ»
ä¿é²ããã°ã©ã ïŒ
ã³ãããæ³¢ããã£ãŠæµè¡ç¹°ãè¿ãããããªããšãªãããã£ãæ°ããããããæ ªãæµè¡ããšå¥ã®æ ªãé§éãããã
æ®éã®SFã ãšç¡å®³ãªã¯ãã ã£ããã®ããå¿
ãã©ããã§æ害ã«ãªã£ãŠããã«é
·ãããšã«ãªããã ãã©ããã
æ¯ãæã£ãŠæ¯ãå¶ã(å€ç°ããŠèŽæ»æ§ãç²åŸããå¯èœæ§ããããããªã)
ã¹ãŽã€çºæ³ïŒ
éçåã®SARS-CoV-2ãšåæã«ææãããšãSARS-CoV-2ã®å¢æ®ããã»ã¹ãä¹ã£åã£ãŠDIç²åãè€è£œã
ã²ãã ãçããããã§SARS-CoV-2ããçŽ æ©ãèªå·±è€è£œããå¢æ®ãé»æ¢ããŠããŸã
éçåã®SARS-CoV-2ãšåæã«ææãããšãSARS-CoV-2ã®å¢æ®ããã»ã¹ãä¹ã£åã£ãŠDIç²åãè€è£œã
ã²ãã ãçããããã§SARS-CoV-2ããçŽ æ©ãèªå·±è€è£œããå¢æ®ãé»æ¢ããŠããŸã
ã¯ã¯ãã³ã§ãæãŠã€ã«ã¹å€ã§ããªãã¢ãããŒãã害è«é§é€ã®ããã«äžåŠåãã害è«ãæŸã€ã®ãšäŒŒãŠãããªã
ãããã話èŠããšç¥æµã®æããããšãããã®ã«ã€ããŠæ¹ããŠèããŠããŸããª^^;
ãã®ãã¥ãŒã¹ãèŠãŠçã£å
ã«ãåãç©ã«ã¯åãç©ãã¶ã€ãããã ãïŒããšããèšèãåºãŠãã人ã¯å°ãªãã¯ãªãããšæãããã
ãªãã»ã©
å㞠次ãž